Open AccessInhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
Author(s) -
Haining Wang,
Yanrong Wang,
Guoqiang Liu,
Zhe Liu,
Peixian Wu,
Xiao-Ling Wei,
Tianpei Hong
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.7240
Subject(s) - nonalcoholic fatty liver disease , rosiglitazone , steatosis , medicine , fatty liver , oil red o , endocrinology , inflammation , fibrosis , disease , adipose tissue , receptor , adipogenesis
To investigate the effects of rosiglitazone (RGZ) on expression of interleukin-18 (IL-18) and caspase-1 in liver of non-alcoholic fatty liver disease (NAFLD) rats.